These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37748817)

  • 21. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
    Rockey DC; Seeff LB; Rochon J; Freston J; Chalasani N; Bonacini M; Fontana RJ; Hayashi PH;
    Hepatology; 2010 Jun; 51(6):2117-26. PubMed ID: 20512999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID-19 in a patient under anastrozole therapy-A case report.
    Lischka W; Kriegshäuser G
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2028. PubMed ID: 38577842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
    Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Jobanputra P; Burls A; Cabello JB; Gálvez Muñoz JG; Saiz Cuenca ES; Fry-Smith A
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007649. PubMed ID: 21328299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zanubrutinib-induced liver injury: a case report and literature review.
    Atallah E; Wijayasiri P; Cianci N; Abdullah K; Mukherjee A; Aithal GP
    BMC Gastroenterol; 2021 May; 21(1):244. PubMed ID: 34051727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Keystone E; Heijde Dv; Mason D; Landewé R; Vollenhoven RV; Combe B; Emery P; Strand V; Mease P; Desai C; Pavelka K
    Arthritis Rheum; 2008 Nov; 58(11):3319-29. PubMed ID: 18975346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Certolizumab pegol: in rheumatoid arthritis.
    Duggan ST; Keam SJ
    BioDrugs; 2009; 23(6):407-17. PubMed ID: 19894782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.
    Licata A; Puccia F; Lombardo V; Serruto A; Minissale MG; Morreale I; Giannitrapani L; Soresi M; Montalto G; Almasio PL
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):226-232. PubMed ID: 29120909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.
    Niijima K; Niijima Y; Okada S; Yamada M
    Ann Hepatol; 2017; 16(2):308-311. PubMed ID: 28233736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature.
    Xia C; Liu Y; Yao H; Zhu W; Ding J; Jin J
    J Int Med Res; 2020 Apr; 48(4):300060520917569. PubMed ID: 32293220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.
    Kang YM; Park YE; Park W; Choe JY; Cho CS; Shim SC; Bae SC; Suh CH; Cha HS; Koh EM; Song YW; Yoo B; Lee SS; Park MC; Lee SH; Arendt C; Koetse W; Lee SK
    Korean J Intern Med; 2018 Nov; 33(6):1224-1233. PubMed ID: 29294598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.
    Rochon J; Protiva P; Seeff LB; Fontana RJ; Liangpunsakul S; Watkins PB; Davern T; McHutchison JG;
    Hepatology; 2008 Oct; 48(4):1175-83. PubMed ID: 18798340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
    Wang JB; Huang A; Wang Y; Ji D; Liang QS; Zhao J; Zhou G; Liu S; Niu M; Sun Y; Tian H; Teng GJ; Chang BX; Bi JF; Peng XX; Xin S; Xie H; Ma X; Mao YM; Liangpunsakul S; Saxena R; Aithal GP; Xiao XH; Zhao J; Zou Z
    Aliment Pharmacol Ther; 2022 May; 55(10):1297-1310. PubMed ID: 35362188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature.
    Ault TA; Braxton DR; Watson RA; Marcus AO; Fong TL
    J Med Case Rep; 2023 Feb; 17(1):33. PubMed ID: 36732814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
    Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
    Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.
    Funada M; Nawata M; Nawata A; Miyamoto T; Saito K; Tanaka Y
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):11-15. PubMed ID: 32687015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.